$14 Billion Of Device M&A Activity In Q3, More On The Way
This article was originally published in The Gray Sheet
Propelled by the completion of two large acquisitions, the previous quarter was a strong one for device industry M&A activity, and indicators suggest the deal making will continue, PricewaterhouseCoopers says.
You may also be interested in...
Market-leading orthopedic firms have mostly come up with incremental product updates in response to the growing tide of more technology-heavy upstarts. That is what makes Stryker’s $1.65 billion acquisition of MAKO Surgical stand out.
Medtronic hopes the $200 million purchase of telehealth firm Cardiocom will enhance its ability to respond to increasing demands on hospitals to better manage patient outcomes and costs. It will also greatly expand its customer base.
Abbott Laboratories announced July 15 it has entered into agreements to purchase stent manufacturer IDev Technologies and ophthalmic device company OptiMedica Corp. The acquisitions are intended to bolster the company’s medical device unit in the vascular and vision care businesses, respectively.